Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3041184	u-inh-o	— (—)	48	123	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Tuberculosis

42.27

17.28

2.8

1.6

—

Abnormal findings on diagnostic imaging of lung

10.72

10.23

2.1

2.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

7.39

8.31

2.1

2.7

—

ILD medications: immunosuppressive drugs

8.74

7.84

2.4

2.6

—

Certain infectious and parasitic diseases

8.51

7.05

2.7

—

ILD medications

4.68

6.74

2.5

—

First line medication for Crohn's disease

4.46

6.41

2.5

2.6

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.58

6.33

2.4

2.5

—

Any gastric operation

8.78

5.99

2.4

2.9

—

GASTRO-related operations

8.78

5.99

2.4

2.9

—

Excluding asthma or asthma-COPD overlap

7.51

5.90

2.3

2.9

—

COPD differential diagnosis

7.51

5.90

2.3

2.9

—

ILD differential diagnosis

7.51

5.90

2.3

2.9

—

L04AX Other immunosuppressants

5.83

5.51

2.6

2.9

—

Certain infectious and parasitic diseases

8.14

5.40

2.5

2.9

—

Second line medication for Crohn's disease

5.60

5.36

2.6

2.8

—

Autoimmune diseases excluding thyroid diseases

3.86

4.93

2.8

2.3

—

Persons with potential health hazards related to communicable diseases

6.06

4.56

2.8

2.1

—

Asthma, unspecified (mode)

8.47

4.38

2.8

2.5

—

Pneumonias (Asthma/COPD co-morbidities)

3.60

4.29

2.8

2.5

—

Other pulmonary diagnosis

6.01

4.26

2.5

2.9

—

Examination and observation for other reasons

5.79

3.99

3.3

2.1

—

Asthma, unspecified (mode), excluding more controls

8.55

3.95

2.9

2.6

—

Polyarthropathies

3.98

3.80

2.6

2.8

—

Neurological diseases

3.70

3.76

2.5

2.7

—

Influenza and pneumonia

3.29

3.75

2.8

2.4

—

Diseases of the respiratory system

5.51

3.73

1.9

3.2

—

Oral corticosteroids

3.30

3.68

2.7

2.4

—

Bacterial pneumonia (organism specified)

5.04

3.64

2.7

2.0

—

3.39

3.60

2.9

2.7

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.39

3.60

2.9

2.7

—

Abnormalities of breathing

3.39

3.55

2.9

2.6

—

Used for control exclusion in common control thyroid runs

3.29

3.48

2.3

—

Autoimmune diseases excluding thyroid diseases, strict definition

3.33

3.40

2.9

2.3

—

Gout, FINNGEN

5.70

3.33

3.3

2.5

—

Autoimmune diseases

3.18

3.33

2.3

—

Asthma (only as main-diagnosis), excluding more controls

5.72

3.32

3.3

3.0

—

All pneumoniae

3.12

3.30

2.9

2.4

—

Complications of surgical and medical care, not elsewhere classified

3.09

3.29

2.5

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3.08

3.26

2.9

2.4

—

Rheumatoid arthritis

5.52

3.20

2.0

3.2

—

Inflammatory bowel disease treatment related agents

3.00

3.16

2.9

2.3

—

Asthma (only as main-diagnosis)

5.21

3.13

3.3

2.9

—

Asthma, excluding more controls

5.21

3.06

2.9

3.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

4.60

3.05

3.0

2.1

—

Contact with and exposure to communicable diseases

4.98

3.03

2.1

2.2

—

Gout, unspecified

5.84

3.02

3.6

2.5

—

Gout

5.03

3.00

3.3

3.1

—

Other bacterial diseases

3.01

2.93

2.1

2.9

—

Asthma (mode)

4.82

2.92

2.9

—

Rheumatoid arthritis, including avohilmo

4.71

2.91

2.0

2.7

—

Fever of other and unknown origin

4.22

2.90

2.2

—

Gout, idiopatic and unspecified

5.39

2.86

3.6

2.4

—

Pleural effusion

6.67

2.86

1.7

2.0

—

Asthma

4.72

2.86

2.9

—

General symptoms and signs

3.10

2.79

3.3

2.4

—

Asthma-related pneumonia

4.44

2.78

2.9

2.6

—

Asthma-related pneumonia or sepsis

4.44

2.78

2.9

2.6

—

Asthma, hospital admissions 3, pneumonia

4.44

2.78

2.9

2.6

—

Any reimbursement code in KELA

4.51

2.74

2.9

2.4

—

Other bacterial diseases

2.78

2.73

2.1

2.7

—

Other cataract

5.30

2.70

2.6

3.7

—

Sulfasalazine

6.00

2.69

2.0

2.5

—

Reimbursement for rheumatic diseases

3.73

2.65

1.9

2.9

—

Disorders of lens

3.67

2.65

1.9

2.9

—

Disorders of other endocrine glands

4.14

2.63

2.1

2.7

—

Diseases of the ear and mastoid process

2.69

2.59

2.4

2.6

—

Pneumonia, organism unspecified

3.00

2.56

2.6

2.5

—

Asthma (diagnoses ohter than nonallergic)

2.93

2.55

2.8

2.4

—

Visual disturbances and blindness

3.46

2.47

2.8

2.4

—

Papulosquamous disorders

3.81

2.46

3.3

2.6

—

Autoimmune diseases related-to ILD

2.94

2.40

3.1

2.4

—

Gastrointestinal diseases

3.76

2.38

1.9

1.7

—

ILD, hospital admissions 1, main diag only

6.25

2.37

2.6

1.5

—

Bacterial pneumoniae

3.71

2.36

3.0

2.1

—

Bacterial pneumonia, not elsewhere classified

3.71

2.36

3.0

2.1

—

Asthma, hospital admission 2, infections

3.26

2.33

2.7

2.4

—

Asthma-related infections

3.26

2.33

2.7

2.4

—

Malignant neoplasm

2.96

2.29

2.3

2.7

—

Solid cancers, helper endpoint

2.95

2.28

2.3

2.7

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

4.62

2.27

1.7

2.4

—

Other/unspecified seropositive rheumatoid arthritis

4.62

2.27

1.7

2.4

—

Seropositive rheumatoid arthritis, wide

4.62

2.27

1.7

2.4

—

ILD, hospital admissions

5.56

2.21

2.6

1.8

—

Interstitial lung disease

5.56

2.21

2.6

1.8

—

Interstitial lung disease endpoints

5.56

2.21

2.6

1.8

—

Other interstitial pulmonary diseases

5.56

2.21

2.6

1.8

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

5.56

2.21

1.6

3.1

—

Spondylopathies

2.86

2.21

1.8

3.0

—

Parasetamol

2.93

2.21

2.6

2.8

—

Disorders of lipoprotein metabolism and other lipidaemias

2.84

2.21

3.3

2.4

—

General examination and investigation of persons without complaint and reported diagnosis

3.80

2.20

3.0

2.1

—

Propionic acid derivatives

4.40

2.19

1.9

2.6

—

Anti-inflammatory and antirheumatic products, non-steroids

4.40

2.19

1.9

2.6

—

External causes of morbidity and mortality

3.13

2.19

2.2

3.3

—

Visual disturbances

3.33

2.17

2.8

2.4

—

Psoriasis

4.29

2.15

3.7

2.5

—

Seropositive rheumatoid arthritis

4.27

2.14

1.7

3.4

—

Diseases of oesophagus, stomach and duodenum

2.51

2.11

2.9

2.5

—

Tramadol

2.70

2.06

2.2

3.0

—

Other disorders of ear

2.53

2.04

2.3

2.6

—

Retinal detachments and breaks

4.00

2.04

2.2

2.6

—

Special screening examination for infectious and parasitic diseases

5.26

2.03

2.8

1.9

—

Benign neoplasms

2.47

2.02

2.0

2.8

—

Gastro-oesophageal reflux disease

2.88

2.01

2.9

2.5

—

Senile cataract

3.27

1.99

1.9

3.2

—

Pure hypercholesterolaemia

2.72

1.97

3.2

2.4

—

Use of hypnotics and sedatives

2.41

1.95

2.7

—

Other (seronegative) rheumatoid arthritis, wide

4.55

1.94

1.8

2.7

—

Bacterial infection, other or unspecified

3.02

1.94

2.5

2.7

—

Cough

3.78

1.93

1.7

2.5

—

Concussion

3.36

1.92

2.3

2.8

—

Substance abuse, excluding more controls

2.96

1.90

2.3

2.7

—

Diseases of the skin and subcutaneous tissue

2.41

1.89

2.6

2.2

—

Bacterial infection, other or unspecified

2.94

1.88

2.5

2.7

—

Symptoms and signs involving the circulatory and respiratory systems

2.50

1.86

1.9

2.6

—

Depression

2.48

1.83

2.3

2.6

—

Other respiratory diseases principally affecting the interstitium

4.17

1.82

2.6

2.1

—

Chronic lower respiratory diseases

2.31

1.76

3.1

2.3

—

Unspecified mental disorder

3.33

1.74

1.7

2.6

—

Chronic sinusitis

3.33

1.74

2.5

2.7

—

COPD/asthma related infections

2.40

1.73

3.0

2.7

—

COPD/asthma/ILD related infections

2.40

1.73

3.0

2.7

—

Substance abuse

2.68

1.72

2.3

2.6

—

All influenza

3.85

1.71

2.0

1.9

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

3.85

1.71

1.4

2.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.80

1.69

2.8

1.6

—

Persons encountering health services for examination and investigation

3.19

1.69

3.0

2.1

—

Asthma, hospital admissions , main diagnosis only

2.52

1.67

3.2

2.3

—

2.24

1.65

2.5

2.6

—

Endocrine, nutritional and metabolic diseases

2.53

1.64

2.6

2.4

—

Intracranial trauma

2.89

1.63

2.3

2.8

—

Any mental disorder

2.31

1.61

2.1

2.8

—

Mycoses

3.57

1.61

3.2

1.9

—

Aplastic and other anaemias

2.72

1.58

2.6

2.7

—

Covid-19 confirmed case

3.00

1.58

3.0

2.8

—

Mood [affective] disorders

2.30

1.57

2.3

2.7

—

Mood disorders

2.30

1.57

2.3

2.7

—

Mental and behavioural disorders due to psychoactive substance use

2.47

1.56

2.3

2.6

—

Other diseases of pleura

2.67

1.54

1.7

2.7

—

Disorders of eyelid, lacrimal system and orbit

2.30

1.49

2.4

2.6

—

Iron deficiency anaemia

2.81

1.48

2.7

2.6

—

Malaise and fatigue

2.84

1.45

4.5

2.1

—

Asthma/COPD (KELA code 203)

2.28

1.44

2.6

2.3

—

Injury, poisoning and certain other consequences of external causes

2.70

1.43

1.9

3.2

—

Presence of other functional implants

2.55

1.42

2.0

3.2

—

Other chronic obstructive pulmonary disease

2.75

1.41

3.2

2.1

—

Diseases of the eye and adnexa

2.37

1.41

2.4

2.5

—

COPD

2.72

1.40

3.2

2.1

—

Codes for special purposes

2.41

1.38

2.7

2.6

—

Provisional assignment of new diseases of uncertain etiology

2.41

1.38

2.7

2.6

—

Sensorineural hearing loss

2.26

1.38

2.0

2.6

—

Coxibs

3.29

1.36

2.2

2.6

—

Psychiatric diseases

2.20

1.36

1.9

3.0

—

Kela-code for severe mental illness

2.94

1.36

1.8

2.6

—

Diseases of liver

2.94

1.36

3.4

2.4

—

Other viral diseases

2.93

1.35

3.0

1.9

—

Acetic acid derivatives and related substances

3.24

1.34

1.8

2.6

—

Medical observation and evaluation for suspected diseases and conditions

2.79

1.33

2.7

2.1

—

Dyspnoea

2.17

1.32

2.5

2.4

—

Anxiety (asthma-related co-morbidities)

2.58

1.31

2.0

2.8

—

Dorsopathies

2.15

1.30

2.4

2.9

—

Low back pain

2.39

1.30

2.6

3.0

—

Mood disorders, excluding more controls

2.15

1.29

2.6

2.9

—

Glaucoma suspect

2.78

1.28

2.6

2.9

—

Diaphragmatic hernia

2.78

1.28

1.4

2.9

—

Spinal stenosis

2.53

1.28

2.5

2.9

—

Later onset COPD

2.85

1.28

3.6

2.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.87

1.25

2.6

2.5

—

Complications of medical and surgical care

2.23

1.24

2.9

2.6

—

Exposure to other specified factors

2.22

1.24

2.4

2.5

—

Other anaemias

2.38

1.22

2.8

—

Fracture of rib(s), sternum and thoracic spine

2.63

1.21

1.6

2.5

—

Symptoms and signs involving the digestive system and abdomen

2.00

1.21

2.8

2.3

—

Neoplasms

2.23

1.20

1.6

2.8

—

Other viral diseases

2.61

1.20

3.0

1.8

—

Persons encountering health services in circumstances related to reproduction

0.00

1.19

0.0

2.7

—

Complications of procedures, not elsewhere classified

2.13

1.19

2.9

2.5

—

Fall on same level involving ice and snow

2.31

1.18

2.3

2.5

—

Nutritional anaemias

2.31

1.18

2.7

2.6

—

Congenital malformations, deformations and chromosomal abnormalities

2.28

1.16

2.2

2.6

—

Disorders of choroid and retina

2.11

1.16

2.6

2.4

—

Other diseases of the digestive system

2.50

1.15

1.4

2.4

—

Persons encountering health services in other circumstances

2.49

1.14

2.8

2.2

—

2.48

1.14

2.2

2.4

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.51

1.14

3.6

2.2

—

Diseases of middle ear and mastoid

2.39

1.13

2.7

2.5

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2.03

1.12

2.0

2.6

—

Headache

2.50

1.12

1.2

2.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.30

1.11

2.7

—

Congenital malformations, deformations and chromosomal abnormalities

2.30

1.11

2.0

2.5

—

Malignant neoplasm of digestive organs

2.47

1.10

1.8

2.9

—

All kidney diseases

2.01

1.10

1.8

2.7

—

Conductive and sensorineural hearing loss

2.09

1.08

2.0

2.5

—

COPD, hospital admission 2, with asthma infections

2.38

1.07

3.6

2.6

—

Any event in cancer register

2.04

1.06

1.7

3.0

—

Intracranial injury

2.14

1.06

2.7

2.5

—

Renal tubulo-interstitial diseases

1.97

1.04

1.6

2.8

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.97

1.04

2.1

2.6

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.95

1.03

1.9

2.6

—

Accidents

1.96

1.03

2.7

2.9

—

Other external causes of accidental injury

1.96

1.03

2.7

2.9

—

COPD, hospital admissions 1, only main diagnosis

2.25

1.00

2.0

2.9

—

Bronchitis

1.87

1.00

2.3

2.6

—

Metabolic disorders

1.89

1.00

3.7

2.5

—

Diseases of pulp and periapical tissues, including avohilmo

1.90

0.99

2.1

2.7

—

Benzodiazepine use

1.91

0.98

2.3

2.5

—

Exposure to unspecified factor

1.89

0.97

2.1

2.7

—

Anxiety disorders, excluding more controls

1.98

0.96

2.9

—

Finngen Rheumatological endpoints

1.83

0.96

2.0

2.8

—

Tonsillectomy and adenotomy

2.32

0.95

1.5

2.6

—

COPD, hospital admissions

2.31

0.95

3.2

2.5

—

COPD related to multimorbidity

2.30

0.95

3.2

2.5

—

COPD, early/later onset

2.30

0.95

3.2

2.5

—

Hypothyroidism, other/unspecified

1.79

0.94

2.1

2.6

—

Any death

1.93

0.94

3.1

2.4

—

Diseases of oral cavity, salivary glands and jaws

2.06

0.93

1.6

2.3

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.22

0.93

2.5

2.7

—

Other neurological diseases

1.90

0.93

1.9

2.7

—

Other disorders of skin and subcutaneous tissue

1.88

0.93

1.9

2.8

—

Malignant neoplasm, wide definition for exclusion

2.04

0.92

1.7

3.0

—

All anxiety disorders

2.15

0.91

2.0

2.5

—

Diseases of pulp and periapical tissues and dental caries

1.95

0.90

1.6

2.9

—

Transient ischemic attack

2.11

0.90

1.7

2.8

—

Ischemic heart diseases

1.92

0.89

2.6

—

Glaucoma

2.06

0.89

2.7

—

Other chronic obstructive pulmonary disease, including avohilmo

2.07

0.88

3.2

2.4

—

Renal failure

2.04

0.88

1.3

2.8

—

Chronic apical periodontitis

1.79

0.87

2.5

—

Dentofacial anomalies [including malocclusion]

2.01

0.86

2.3

2.5

—

Lower back pain or/and sciatica

1.81

0.85

2.7

2.6

—

Necrosis of pulp, including avohilmo

1.93

0.84

2.5

2.6

—

Bleeding

1.78

0.83

2.1

2.6

—

Cardiac arrhythmias

1.95

0.83

4.0

2.4

—

Erysipelas

1.91

0.82

2.8

2.6

—

Carpal tunnel syndrome

1.89

0.82

2.2

2.7

—

Sleep disorders (combined)

1.75

0.81

1.6

2.8

—

Other diseases of upper respiratory tract

1.74

0.79

2.5

2.6

—

Other dorsopathies, not elsewhere classified

1.81

0.79

2.6

2.9

—

Heart failure,strict

1.84

0.78

2.5

2.8

—

Asthma, including avohilmo

1.72

0.78

2.6

2.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.75

0.77

2.3

2.7

—

Oxycodone

2.15

0.76

1.6

3.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

2.15

0.76

2.4

2.6

—

Spondylosis

2.14

0.75

2.4

2.8

—

Selective serotonin reuptake inhibitors

1.68

0.75

3.4

2.4

—

Acute sinusitis

2.10

0.75

3.8

2.6

—

Alcohol use disorder, ICD-based

2.08

0.74

2.4

2.1

—

Obesity due to excess calories

2.08

0.74

2.0

2.7

—

Diverticular disease of intestine

1.86

0.74

1.7

2.6

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.07

0.74

2.4

2.1

—

Other soft tissue disorders, not elsewhere classified

1.65

0.74

2.0

2.7

—

Other antidepressants

1.65

0.73

2.9

2.4

—

Other and unspecified anaemias

1.99

0.72

3.0

2.8

—

Heart failure, not strict

1.76

0.71

3.0

2.7

—

Implicit Sepsis

1.76

0.71

1.9

2.8

—

Pain in throat and chest

1.75

0.71

2.3

2.6

—

Mental and behavioural disorders due to alcohol

1.92

0.70

2.4

—

Ischaemic heart disease, wide definition

1.73

0.70

2.9

2.7

—

Coxarthrosis

1.94

0.70

2.0

3.0

—

Erysipelas

1.92

0.70

2.8

2.7

—

Other arthrosis

1.92

0.70

2.0

2.9

—

Percutaneous Coronary Intervention

1.72

0.70

2.7

2.6

—

Coronary revascularization (ANGIO or CABG)

1.71

0.69

2.7

2.6

—

Cardiovascular diseases

1.92

0.69

2.2

—

Injuries to the thorax

1.85

0.68

1.6

2.6

—

Acute upper respiratory infections of multiple and unspecified sites

1.67

0.68

2.7

2.4

—

Coxarthrosis [arthrosis of hip](FG)

1.85

0.67

2.0

3.3

—

Other acute lower respiratory infections

1.83

0.67

2.0

2.7

—

Implicit Sepsis

1.65

0.67

1.9

2.9

—

Other medical care

1.80

0.66

3.0

2.4

—

Implicit bacterial Sepsis

1.80

0.66

1.2

2.9

—

Diseases of the digestive system

1.78

0.66

1.4

2.5

—

STROKE

1.79

0.65

3.6

2.8

—

Disorders of synovium and tendon

1.75

0.64

2.8

2.6

—

Persons encountering health services in other circumstances, wide

1.62

0.64

3.3

2.4

—

Dorsalgia

1.65

0.63

2.6

2.9

—

Hypothyroidism, strict autoimmune

1.73

0.63

2.2

2.5

—

Abnormal findings on examination of blood, without diagnosis

1.70

0.62

2.6

—

Arthropathies

1.62

0.62

2.3

2.7

—

Constipation

1.58

0.61

1.6

2.8

—

Extrapyramidal and movement disorders

0.00

0.60

0.0

2.8

—

Opioids

1.54

0.59

1.9

2.8

—

Genitourinary diseases

1.77

0.59

1.5

3.5

—

Falls/tendency to fall

1.62

0.58

2.3

2.6

—

Symptoms and signs involving the skin and subcutaneous tissue

1.73

0.58

2.2

2.6

—

All-cause Heart Failure

1.69

0.57

2.5

2.7

—

Heart failure, strict

1.69

0.57

2.5

2.7

—

Diseases of the musculoskeletal system and connective tissue

1.67

0.57

2.2

2.8

—

Coronary atherosclerosis

1.65

0.56

3.2

2.6

—

Diabetes medication

1.52

0.55

2.4

2.6

—

Abdominal and pelvic pain

1.51

0.55

2.0

2.3

—

Injuries to the head

1.49

0.54

1.9

2.7

—

Episodal and paroxysmal disorders

1.48

0.54

2.7

2.5

—

Acute upper respiratory infections

1.46

0.53

2.9

2.5

—

Soft tissue disorders

1.45

0.53

2.6

2.7

—

Hypertension, essential

1.54

0.52

2.0

2.4

—

Hypertensive diseases

1.54

0.52

2.0

2.4

—

Hypertension

1.54

0.52

2.0

2.4

—

Diseases of arteries, arterioles and capillaries

1.53

0.52

2.5

2.7

—

Chronic diseases of tonsils and adenoids

1.52

0.52

3.5

2.5

—

Neurotic, stress-related and somatoform disorders

1.58

0.49

2.9

2.5

—

Major coronary heart disease event

1.56

0.49

2.7

2.6

—

Symptoms and signs involving the urinary system

1.57

0.49

1.9

2.6

—

Hard cardiovascular diseases

1.55

0.49

2.7

2.5

—

Mycoses

1.56

0.49

2.9

2.6

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.54

0.49

1.9

2.8

—

Emergency coronary revascularization (for ACS)

1.52

0.48

2.7

2.6

—

Dental caries, including avohilmo

1.49

0.48

2.9

2.6

—

Caries of dentine, including avohilmo

1.49

0.48

2.9

2.6

—

Type 2 diabetes, wide definition

1.49

0.48

2.9

2.6

—

Anxiety disorders

1.48

0.47

2.9

2.5

—

Shoulder lesions

1.46

0.47

1.7

2.8

—

Other heart diseases, wide

1.43

0.46

3.7

2.4

—

Hernia

1.42

0.45

2.1

2.9

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.47

0.44

2.3

2.5

—

Other retinal disorders

1.62

0.43

3.0

2.5

—

Polyp of the female genital tract

0.00

0.43

0.0

3.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.42

0.43

2.6

2.7

—

Open wound of head

1.61

0.43

2.2

2.3

—

Diseases of male genital organs

1.58

0.43

1.4

2.8

—

Infections of the skin and subcutaneous tissue

1.60

0.42

3.4

2.3

—

Obesity

1.56

0.42

2.0

2.5

—

Obesity and other hyperalimentation

1.55

0.42

2.0

2.5

—

Type 2 diabetes

1.37

0.42

2.6

—

Alcohol use disorder, Swedish definition

1.53

0.41

2.4

2.6

—

Angina pectoris

1.51

0.41

2.8

2.6

—

Medicines for HER+ breast cancer

0.00

0.41

0.0

2.7

—

Varicose veins

1.51

0.41

2.4

2.6

—

Other bacterial intestinal infections

0.00

0.41

0.0

3.0

—

Herpesviral [herpes simplex] infections

0.00

0.41

0.0

2.5

—

Speech therapy

0.00

0.41

0.0

2.4

—

Migraine with aura

0.00

0.41

0.0

2.5

—

Obesity, other/unspecified

0.00

0.41

0.0

3.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.50

0.41

1.6

2.9

—

Exclusions for E4_PCOS_CONSORTIUM

1.49

0.41

2.6

2.5

—

Diabetes, insulin treatment (Kela reimbursement)

1.34

0.40

2.6

2.7

—

Acute tubulo-interstitial nephritis

1.49

0.40

2.0

2.9

—

Other systemic involvement of connective tissue

0.00

0.40

0.0

2.1

—

Lyme disease

0.00

0.40

0.0

2.8

—

Spirochaetal infections, other/unspecified

0.00

0.40

0.0

2.8

—

Other spirochaetal diseases

0.00

0.40

0.0

2.8

—

Other spirochaetal diseases

0.00

0.40

0.0

2.8

—

Depression or dysthymia

1.45

0.40

2.0

2.7

—

Other nutritional deficiencies

1.43

0.39

2.0

2.5

—

Dermatitis

1.42

0.39

1.6

2.4

—

Combinations of oral blood glucose lowering drugs

0.00

0.39

0.0

2.9

—

Other and unspecified effects of external causes

0.00

0.39

0.0

2.3

—

Systemic connective tissue disorders

0.00

0.39

0.0

2.2

—

1.41

0.39

2.4

2.6

—

Statin medication

1.41

0.38

3.4

2.1

—

1.38

0.38

2.4

2.6

—

Dental operations

1.47

0.37

2.0

—

Insomnia

1.37

0.34

1.2

2.6

—

Sleep disorders

1.31

0.33

1.2

2.7

—

Pain (limb, back, neck, head abdominally)

1.40

0.32

2.3

2.6

—

Disorders of the thyroid gland

1.34

0.31

2.0

2.6

—

Other (not insulin) diabetes medications

1.26

0.30

2.4

2.7

—

Nerve, nerve root and plexus disorders

1.32

0.29

2.0

2.7

—

Persons encountering health services for specific procedures and health care

1.30

0.28

3.3

2.4

—

Other diseases of hard tissues of teeth

1.36

0.24

3.6

2.4

—

Arthrosis

1.31

0.23

1.8

2.9

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.32

0.23

2.4

2.8

—

Rotator cuff syndrome

1.28

0.23

2.0

2.8

—

Other intervertebral disc disorders

1.25

0.22

2.6

3.0

—

Postmenopausal atrophic vaginitis

0.00

0.22

0.0

3.5

—

Other menopausal disorders

0.00

0.22

0.0

3.9

—

Dizziness and giddiness

1.20

0.21

1.8

2.6

—

Dysplasia of cervi uteri

0.00

0.21

0.0

3.6

—

Disorders of psychological development

0.00

0.21

0.0

1.5

—

D07AA Corticosteroids, weak (group I)

0.00

0.21

0.0

1.6

—

Graves disease, strict definition

0.00

0.21

0.0

1.7

—

Pruritus

0.00

0.21

0.0

2.0

—

Other disorders of bladder

0.00

0.21

0.0

1.8

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

2.1

—

Valvular operations

0.00

0.21

0.0

2.5

—

Hypotension

0.00

0.21

0.0

1.9

—

Restless leg syndrome

0.00

0.21

0.0

1.9

—

Use of levodopa decarboxylase inhibitor

0.00

0.21

0.0

1.9

—

Parkinson's disease, strict definition

0.00

0.21

0.0

1.9

—

Parkinson's disease

0.00

0.21

0.0

1.9

—

Other bursopathies

0.00

0.21

0.0

2.5

—

Lateral epicondylitis

0.00

0.21

0.0

2.5

—

Other disorders of the musculoskeletal system and connective tissue

0.00

0.21

0.0

1.9

—

Cholecystitis

0.00

0.21

0.0

1.8

—

Atrophic disorders of skin

0.00

0.21

0.0

2.4

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

2.1

—

Parkinson's disease, including avohilmo

0.00

0.21

0.0

2.0

—

Injury of muscle and tendon at lower leg level

0.00

0.21

0.0

2.3

—

Superficial injury of thorax

0.00

0.21

0.0

2.3

—

Superficial injury of abdomen, lower back and pelvis

0.00

0.21

0.0

1.6

—

Schizophrenia

0.00

0.21

0.0

2.3

—

Radiculopathy

0.00

0.21

0.0

3.1

—

Malignant melanoma, including Hilmo

0.00

0.21

0.0

2.2

—

Myocardial infarction, with ST-elevation

0.00

0.21

0.0

1.9

—

Generalized anxiety disorder

0.00

0.21

0.0

1.6

—

Other bacterial intestinal infections

0.00

0.21

0.0

1.9

—

DVT of lower extremities

0.00

0.21

0.0

2.5

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

2.4

—

Other and unspecified nerve root and plexus disorders, also in other diseases

0.00

0.21

0.0

2.5

—

Cervicalgia

0.00

0.21

0.0

2.9

—

Fracture of skull and facial bones

0.00

0.21

0.0

2.3

—

Enthesopathies of lower limb, excluding foot

0.00

0.21

0.0

2.7

—

Complications predominantly related to the puerperium

0.00

0.21

0.0

2.9

—

All dysplastic lesions of the cervix uteri

0.00

0.21

0.0

2.4

—

Disorders of conjunctiva

1.18

0.21

2.8

2.5

—

Migraine with aura and triptan purchases

0.00

0.21

0.0

2.2

—

Other diseases of liver

0.00

0.21

0.0

1.9

—

Other and unspecified urticaria

0.00

0.21

0.0

1.6

—

Persistent mood disorders

0.00

0.21

0.0

2.4

—

Acute pancreatitis

0.00

0.21

0.0

2.4

—

L02BG Aromatase inhibitors

0.00

0.21

0.0

2.6

—

Allergic contact dermatitis

0.00

0.21

0.0

1.8

—

Coagulation defects, purpura and other haemorrhagic conditions

0.00

0.21

0.0

1.8

—

Adverse effects, not elsewhere classified

0.00

0.21

0.0

1.8

—

Bipolar affective disorders

0.00

0.21

0.0

2.4

—

Other CVD

0.00

0.21

0.0

2.1

—

Nontraumatic intracranial haemmorrhage

0.00

0.21

0.0

1.9

—

Other systemic involvement of connective tissue (FG)

0.00

0.20

0.0

2.9

—

Caries of enamel

1.27

0.20

4.0

2.3

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.25

0.20

1.2

2.8

—

Aneurysms, operations, SAH

0.00

0.20

0.0

2.4

—

Other and unspecified polyneuropathies, also in other diseases

0.00

0.20

0.0

2.6

—

Other extrapyramidal and movement disorders in other diseases

0.00

0.20

0.0

2.1

—

Acute pancreatitis (for exclusion)

0.00

0.20

0.0

2.5

—

Other diseases of blood and blood-forming organs, wide

0.00

0.20

0.0

2.4

—

Other fall from one level to another

0.00

0.20

0.0

2.1

—

Other noninfective gastroenteritis and colitis

0.00

0.20

0.0

2.4

—

Codeine

1.21

0.20

2.2

2.8

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1.22

0.20

2.0

2.9

—

Dental pulpitis, including avohilmo

1.18

0.19

1.7

2.7

—

Other diseases of intestines

1.24

0.19

2.7

2.5

—

Type 2 diabetes, strict (exclude DM1)

1.25

0.19

2.4

2.7

—

Type 2 diabetes, definitions combined

1.24

0.19

2.4

2.7

—

Type 2 diabetes, definitions combined, including avohilmo

1.23

0.19

2.4

2.7

—

Injuries to the wrist and hand

1.21

0.18

2.6

—

Other diseases of urinary system

1.19

0.18

2.1

2.7

—

Diabetes, varying definitions

1.17

0.18

1.9

2.6

—

Diabetes mellitus

1.17

0.18

1.9

2.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.15

0.18

2.3

2.7

—

Codeine or tramadol medication

1.15

0.17

2.0

2.6

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.16

0.10

2.2

2.5

—

Injuries to the shoulder and upper arm

1.03

0.09

3.6

2.5

—

Sleep apnoea

1.14

0.09

2.2

2.6

—

Intestinal infectious diseases

1.11

0.09

2.2

2.7

—

Biguanides

1.08

0.09

2.7

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.12

0.08

2.4

—

Dermatitis and eczema

1.06

0.08

3.0

2.5

—

Other diseases of spinal cord

0.00

0.0

1.7

—

Right bundle-branch block

0.00

0.0

1.4

—

Glomerulonephritis

0.00

0.0

1.9

—

Vascular diseases of the intestine

0.00

0.0

1.5

—

Need for other prophylactic measures

0.00

0.0

1.7

—

Other/unspecified disorders of vestibular function

0.00

0.0

1.7

—

Nontoxic single thyroid nodule

0.00

0.0

2.3

—

Artrosis, including avohilmo

0.88

0.00

1.8

2.9

—

Other and unspecified injuries of lower leg

0.00

0.0

1.8

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.6

—

Event of undetermined intent

0.00

0.0

1.7

—

Agranulocytosis

0.00

0.0

1.7

—

Congenital malformations of eye, ear, face and neck

0.00

0.0

1.6

—

Intracerebral haemorrhage

0.00

0.0

1.4

—

Other infective otitis externa

0.00

0.0

1.7

—

Other specified/unspecified bacterial intestinal infections

0.00

0.0

1.9

—

Polymyalgia rheumatica

0.00

0.0

1.7

—

Endocarditis

0.00

0.0

1.8

—

Herpesviral keratitis and keratoconjunctivitis

0.00

0.0

1.7

—

Campylobacter enteritis

0.00

0.0

1.2

—

Cerebral aneurysm, nonruptured

0.00

0.0

1.4

—

Oral leukoplakia, including avohilmo

0.00

0.0

1.2

—

Other disorders of cornea

0.00

0.0

1.7

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.8

—

Disorders of optic nerve and visual pathways

0.00

0.0

1.8

—

Malignant neoplasm of breast, HER-positive

0.00

0.0

2.3

—

Endovascular or surgical operations to intracerebral aneurysms

0.00

0.0

1.5

—

Rheumatic valve diseases

0.00

0.0

1.6

—

Benign neoplasm: Adrenal gland

0.00

0.0

1.6

—

Alcohol abuse, main dg, excluding more controls

0.00

0.0

2.0

—

Fracture of neck

0.00

0.0

1.9

—

Other disorders of penis

0.00

0.0

3.2

—

Schizoaffective disorder

0.00

0.0

1.0

—

Bullous disorders

0.00

0.0

1.5

—

Other sexually transmitted chlamydial diseases

0.00

0.0

1.8

—

Volume depletion

0.00

0.0

1.6

—

Giant cell arteritis with polymyalgia rheumatica

0.00

0.0

1.6

—

Anogenital herpesviral [herpes simplex] infection

0.00

0.0

1.9

—

Other and/or unspecified nontoxic goitre

0.00

0.0

2.0

—

Benign neoplasm of major salivary glands

0.00

0.0

1.7

—

Congenital malformations of cardiac septa

0.00

0.0

1.2

—

Speech disturbances, not elsewhere classified

0.00

0.0

1.8

—

Benign neoplasm: Long bones of lower limb

0.00

0.0

1.6

—

Other pulmonary heart/vessel disease

0.00

0.0

1.2

—

Faecal incontinence

0.00

0.0

1.2

—

Infective bursitis

0.00

0.0

1.2

—

Hyperkinetic disorders, excluding more controls

0.00

0.0

1.4

—

Amenorrhoea

0.00

0.0

2.4

—

Scar conditions and fibrosis of skin

0.00

0.0

1.2

—

Hydrocephalus

0.00

0.0

1.2

—

Disorder of lipoprotein metabolism, unspecified

0.00

0.0

1.7

—

Other and unspecified disorders of white blood cells

0.00

0.0

1.2

—

Type 1 diabetes, strict definition

0.00

0.0

1.4

—

Other disorders of pigmentation

0.00

0.0

1.2

—

Other specified and unspecified disorders of eye and adnexa

0.00

0.0

1.4

—

Additional codes for the location of defect, injury or illness

0.00

0.0

1.7

—

Residual foreign body in soft tissue

0.00

0.0

1.3

—

Noninfectious colitis NAS

0.00

0.0

1.7

—

LSIL lesion of the cervix uteri

0.00

0.0

1.4

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.7

—

Disorders of tooth development and eruption

0.00

0.0

2.4

—

Corns and callosities

0.00

0.0

1.2

—

Use of biperiden

0.00

0.0

1.7

—

Lactose intolerance

0.00

0.0

1.7

—

Specific development disorders of scholastic skills

0.00

0.0

1.6

—

L01XE Protein kinase inhibitors

0.00

0.0

1.2

—

Other diseases of gallbladder

0.00

0.0

1.6

—

Heart failure and hypertrophic cardiomyopathy

0.00

0.0

1.6

—

Endometriosis of ovary

0.00

0.0

3.9

—

Temporal arteritis

0.00

0.0

1.6

—

Other orthopaedic follow-up care

0.00

0.0

2.0

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.6

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.00

0.0

1.7

—

Urethritis and urethral syndrome

0.00

0.0

1.2

—

Use of antiglaucoma preparations and miotics

0.00

0.0

1.7

—

Other specified/unspecified soft tissue disorders

0.00

0.0

1.2

—

Coeliac disease

0.00

0.0

1.8

—

Disorders of continuity of bone

0.00

0.0

1.7

—

Pedal cyclist injured in collision with motor vehicle

0.00

0.0

1.7

—

Congenital malformations and deformations of the musculoskeletal system

0.00

0.0

1.6

—

Burn and corrosion of head and neck

0.00

0.0

1.7

—

Bicuspidal aortic valve syndrome

0.00

0.0

1.8

—

Other specified disorders of kidney and ureter

0.00

0.0

1.2

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

0.0

1.8

—

Unspecified chronic bronchitis

0.00

0.0

2.0

—

Hidradenitis suppurativa

0.00

-0.00

0.0

1.6

—

Hypertrophic scar

0.00

-0.00

0.0

1.2

—

Dermatitis due to substances taken internally

0.00

-0.00

0.0

2.0

—

Lichen sclerosus et atrophicus

0.00

-0.00

0.0

1.6

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

0.00

-0.00

0.0

1.6

—

Diabetic maculopathy

0.00

-0.00

0.0

1.7

—

Other contact dermatitis

0.00

-0.00

0.0

1.8

—

Congenital malformations of aortic and mitral valves

0.00

-0.00

0.0

1.8

—

Congenital deformities of feet

0.00

-0.00

0.0

1.6

—

Malignant neoplasm of bladder, including Hilmo

0.00

-0.00

0.0

2.0

—

Cirrhosis of liver, NAS

0.00

-0.00

0.0

1.2

—

Pilonidal cyst

0.00

-0.00

0.0

2.3

—

Use of selegiline

0.00

-0.00

0.0

1.6

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

-0.00

0.0

1.6

—

Puerperal sepsis

0.00

-0.00

0.0

2.0

—

Amyloidosis, other/unspecified

0.00

-0.00

0.0

1.2

—

Disorders of iron metabolism

0.00

-0.00

0.0

1.2

—

Dissection of aorta

0.00

-0.00

0.0

1.8

—

Prurigo nodularis

0.00

-0.00

0.0

1.2

—

Other arterial embolism and thrombosis

0.00

-0.00

0.0

1.6

—

Episcleritis

0.00

-0.00

0.0

1.9

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.4

—

Sicca syndrome [Sjögren]

0.00

-0.00

0.0

1.7

—

Spondylolisthesis/Spondylolysis

0.00

-0.00

0.0

3.1

—

Universal erythroderma, KELA reimbursement

0.00

-0.00

0.0

1.6

—

Total colectomy

0.00

-0.00

0.0

1.6

—

Muscle strain

0.00

-0.00

0.0

1.2

—

Other specified/unspecified systemic involvement of connective tissue

0.00

-0.00

0.0

1.4

—

Laparoscopic right hemicolectomy

0.00

-0.00

0.0

1.6

—

Fibromyalgia

0.00

-0.00

0.0

1.7

—

Total colectomy operation

0.00

-0.00

0.0

1.6

—

Salpingitis and oophoritis

0.00

-0.00

0.0

3.1

—

Unspecified kidney failure

0.00

-0.00

0.0

1.7

—

Benign mammary dysplasia

0.00

-0.00

0.0

3.4

—

Endometriosis of pelvic peritoneum

0.00

-0.00

0.0

3.6

—

Calculus of lower urinary tract

0.00

-0.00

0.0

1.7

—

Myositis

0.00

-0.00

0.0

1.2

—

Reactive arthropathies

0.00

-0.00

0.0

2.6

—

Other noninflammatory disorders of vulva and perineum

0.00

-0.00

0.0

3.5

—

Spermatocele

0.00

-0.00

0.0

3.2

—

Neuromuscular dysfunction of bladder

0.00

-0.00

0.0

1.5

—

Synovial cyst of popliteal space [Baker]

0.00

-0.00

0.0

1.7

—

HSIL lesion of the cervix uteri

0.00

-0.00

0.0

2.3

—

Inflammatory disease of uterus

0.00

-0.00

0.0

2.0

—

Other secondary gonarthrosis

0.00

-0.00

0.0

1.8

—

Uterine polyps

0.00

-0.00

0.0

4.0

—

Endometriosis ASRM stages 1,2

0.00

-0.00

0.0

1.7

—

Cystitis

0.99

-0.00

2.0

2.8

—

Chronic nephritic syndrome

0.00

-0.00

0.0

1.7

—

Prepatellar bursitis

0.00

-0.00

0.0

2.4

—

Plantar fascial fibromatosis

0.00

-0.00

0.0

1.8

—

Neuralgia and neuritis, unspecified

0.00

-0.00

0.0

1.2

—

Orchitis and epididymitis

0.00

-0.00

0.0

3.2

—

Nephrotic syndrome

0.00

-0.00

0.0

1.7

—

Urethral stricture

0.00

-0.00

0.0

1.6

—

Long labour

0.00

-0.00

0.0

2.0

—

Calcific tendinitis of shoulder

0.00

-0.00

0.0

1.5

—

Unspecified/other endometriosis

0.00

-0.00

0.0

3.0

—

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

0.00

-0.00

0.0

1.2

—

Achilles tendinitis

0.00

-0.00

0.0

2.8

—

Pre-eclampsia

0.00

-0.00

0.0

2.6

—

Pneumococcal septicemia

0.00

-0.00

0.0

1.7

—

Atrial septal defect

0.00

-0.00

0.0

1.2

—

Primary hyperparathyroidism

0.00

-0.00

0.0

1.8

—

Raynaud syndrome

0.00

-0.00

0.0

1.7

—

Disorders of synovium and tendon in diseases classified elsewhere

0.00

-0.00

0.0

1.2

—

Maternal care for other conditions predominantly related to pregnancy

0.00

-0.00

0.0

2.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.5

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

2.4

—

Hypercalcemia

0.00

-0.00

0.0

1.2

—

Carcinoma in situ of cervix uteri

0.00

-0.00

0.0

2.0

—

Use of disulfiram, acamprosate or naltrexone

0.00

-0.00

0.0

2.9

—

Spontaneous rupture of synovium and tendon

0.00

-0.00

0.0

1.7

—

Malignant neoplasm of pancreas, including Hilmo

0.00

-0.00

0.0

1.8

—

Other osteochondropathies

0.00

-0.00

0.0

1.7

—

Pathological resorption of teeth

0.00

-0.00

0.0

1.8

—

Alcohol-induced acute pancreatitis

0.00

-0.00

0.0

1.8

—

Chondrocostal junction syndrome [Tietze]

0.00

-0.00

0.0

1.6

—

Viral pneumonia (known virus, not influenza)

0.00

-0.00

0.0

1.2

—

Crohn's disease of large intestine

0.00

-0.00

0.0

1.8

—

Special screening examination for other diseases and disorders

0.00

-0.00

0.0

1.2

—

Giant cell arteritis

0.00

-0.00

0.0

1.6

—

Impacted maxillary molar

0.00

-0.00

0.0

1.6

—

Gingivitis and periodontal diseases

0.86

-0.00

2.7

2.5

—

Nonalcoholic fatty liver disease

0.00

-0.00

0.0

1.6

—

Other/unspecified soft tissue disorders related to use, overuse and pressure

0.00

-0.00

0.0

1.2

—

Other Crohn's disease

0.00

-0.00

0.0

1.6

—

Benign neoplasm of brain and other parts of central nervous system

0.00

-0.00

0.0

1.2

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

0.00

-0.00

0.0

1.8

—

Benign neoplasm: salivary glands, exclude unknown (D119)

0.00

-0.00

0.0

1.6

—

Other specified disorders of muscle

0.00

-0.00

0.0

1.2

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

0.00

-0.00

0.0

1.6

—

Medial epicondylitis

0.00

-0.00

0.0

1.2

—

Mandibular retrognathia

0.00

-0.00

0.0

1.6

—

Melanoma in situ

0.00

-0.00

0.0

1.6

—

Other coagulation defects

0.00

-0.00

0.0

1.8

—

Early lumbar disc prolapse operation

0.00

-0.00

0.0

2.7

—

Olecranon bursitis

0.00

-0.00

0.0

2.3

—

Metatarsalgia

0.00

-0.00

0.0

1.7

—

Other enthesopathy of foot (+metatarsalgia)

0.00

-0.00

0.0

1.7

—

Benign neoplasm of meninges

0.00

-0.00

0.0

2.0

—

Gonarthrosis,primary

0.91

-0.00

1.6

2.6

—

Other follicular disorders

0.00

-0.00

0.0

1.7

—

Other bursitis of knee

0.00

-0.00

0.0

1.2

—

Rosacea

0.00

-0.00

0.0

1.8

—

Disorders of mineral metabolism

0.00

-0.00

0.0

1.6

—

Ingrowing nail

0.00

-0.00

0.0

1.8

—

Other diseases of peritoneum

0.00

-0.00

0.0

1.5

—

Early lumbar disc prolapse, operated

0.00

-0.00

0.0

2.4

—

Alcohol abuse, main dg

0.00

-0.00

0.0

2.4

—

Diseases of peritoneum

0.00

-0.00

0.0

1.8

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.7

—

UC patients in KELA-register (code 208), prior to 1994

0.00

-0.00

0.0

1.2

—

Acne

0.00

-0.00

0.0

1.8

—

Postprocedural disorders of digestive system, not elsewhere classified

0.00

-0.00

0.0

1.6

—

Acne vulgaris

0.00

-0.00

0.0

1.4

—

Sleep apnoea, including avohilmo

1.00

-0.00

2.2

2.5

—

Intestinal adhesions without obstruction

0.00

-0.00

0.0

2.0

—

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

0.00

-0.00

0.0

1.5

—

Crohn disease (strict definition, require KELA, min 2 HDR)

0.00

-0.00

0.0

1.6

—

Mixed connective tissue disease

0.00

-0.00

0.0

1.8

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

1.9

—

Pneumonia due to Streptococcus pneumoniae

0.00

-0.00

0.0

1.6

—

Invasive ventilation

0.00

-0.00

0.0

1.9

—

Cholangitis (primary sclerosing, PSC)

0.00

-0.00

0.0

1.9

—

Disorders of gallbladder, biliary tract and pancreas

1.02

-0.00

2.5

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.7

—

Embolic stroke

0.00

-0.00

0.0

1.6

—

Secondary right heart disease

0.00

-0.00

0.0

1.2

—

Other or ill-defined heart diseases

0.00

-0.00

0.0

1.8

—

Other intracranial haemorrhages

0.00

-0.00

0.0

1.6

—

Other other unspecified disorders of the circulatory system

0.00

-0.00

0.0

1.9

—

Hyphaema and other vascular disorders of iris and ciliary body

0.00

-0.00

0.0

1.6

—

Vertical strabismus

0.00

-0.00

0.0

1.2

—

Intermittent heterotropia

0.00

-0.00

0.0

1.6

—

Disorders of eyelid in diseases classified elsewhere

0.00

-0.00

0.0

1.7

—

Suggestive for eosinophilic asthma

0.00

-0.00

0.0

2.0

—

Disorder of external ear, unspecified

0.00

-0.00

0.0

1.2

—

Corneal scars and opacities

0.00

-0.00

0.0

1.7

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

-0.00

0.0

2.3

—

Deep bite

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Parotid gland

0.00

-0.00

0.0

1.7

—

Intestinal infectious diseases

1.00

-0.00

1.7

2.7

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

2.9

—

Arterial embolism and thrombosis of lower extremity artery

0.00

-0.00

0.0

1.6

—

Atopic conjunctivitis

0.00

-0.00

0.0

1.6

—

Congenital malformations and deformations of the musculoskeletal system

0.00

-0.00

0.0

1.5

—

Convergent concomitant strabismus

0.00

-0.00

0.0

1.5

—

KRA_PSY_EATING, excluding more controls

0.00

-0.00

0.0

1.6

—

Infectious mononucleosis

0.00

-0.00

0.0

1.5

—

Cerebral cysts

0.00

-0.00

0.0

1.6

—

Postprocedural disorders of nervous system

0.00

-0.00

0.0

1.5

—

Eating disorders

0.00

-0.00

0.0

1.8

—

Carcinoma in situ of skin

0.00

-0.00

0.0

1.5

—

Lesion of ulnar nerve

0.00

-0.00

0.0

2.7

—

Varicella [chickenpox]

0.00

-0.00

0.0

3.0

—

Anankastic personality disorder

0.00

-0.00

0.0

1.6

—

Other neurotic disorders

0.00

-0.00

0.0

1.5

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.8

—

Cluster headache, wide

0.00

-0.00

0.0

1.6

—

Other demyelinating diseases of the central nervous system

0.00

-0.00

0.0

1.6

—

Undefined dementia

0.00

-0.00

0.0

1.4

—

Benign neoplasm: Other and unspecified parts of mouth

0.00

-0.00

0.0

1.2

—

Paraplegia, diplegia of upper limbs

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

-0.00

0.0

1.7

—

Panhypopituitarism

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Rectosigmoid junction

0.00

-0.00

0.0

1.5

—

Malnutrition

0.00

-0.00

0.0

1.2

—

Thrombocytopenia, unspecified

0.00

-0.00

0.0

1.5

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.6

—

Benign neoplasm: Choroid

0.00

-0.00

0.0

1.9

—

Benign neoplasm: Cranial nerves

0.00

-0.00

0.0

1.2

—

Intestinal malabsorption

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Caecum

0.00

-0.00

0.0

1.4

—

Other disorders of white blood cells

0.00

-0.00

0.0

1.2

—

Mixed hyperlipidaemia

0.00

-0.00

0.0

1.7

—

Status epilepticus

0.00

-0.00

0.0

1.5

—

Macular pucker

0.00

-0.00

0.0

2.3

—

Lymphoid leukaemia

0.00

-0.00

0.0

1.9

—

Other specified disorders of external ear

0.00

-0.00

0.0

1.8

—

Amblyopia ex anopsia

0.00

-0.00

0.0

1.2

—

Other peripheral vertigo

0.00

-0.00

0.0

1.6

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

0.00

-0.00

0.0

1.8

—

Benign leiomyoma with endometriosis

0.00

-0.00

0.0

3.1

—

Immunodeficiencies

0.00

-0.00

0.0

1.8

—

Abscess of anal and rectal regions

0.00

-0.00

0.0

2.4

—

Benign neoplasm: Tongue

0.00

-0.00

0.0

1.6

—

Other and unspecified abdominal hernia

0.00

-0.00

0.0

1.5

—

Pyothorax

0.00

-0.00

0.0

1.7

—

Myeloid leukaemia

0.00

-0.00

0.0

1.2

—

Hepatic failure, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Other appendicitis

0.00

-0.00

0.0

1.7

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.6

—

Carcinoma in situ of other and unspecified digestive organs

0.00

-0.00

0.0

1.2

—

Obstructed labour due to maternal pelvic abnormality

0.00

-0.00

0.0

2.0

—

Viral pneumonia (unknown virus, not influenza)

0.00

-0.00

0.0

1.9

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.7

—

Other and unspecified rosacea

0.00

-0.00

0.0

1.7

—

Septal defects

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Small intestine

0.00

-0.00

0.0

1.6

—

Carcinoma in situ of breast, intraductal

0.00

-0.00

0.0

2.4

—

Other and unspecified diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.7

—

Collagenous colitis

0.00

-0.00

0.0

1.7

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.8

—

Anorexia (incl.atypical)

0.00

-0.00

0.0

1.6

—

Other epidermal thickening

0.00

-0.00

0.0

1.2

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.8

—

Haemolytic anaemias

0.00

-0.00

0.0

1.8

—

Other and unspecified corneal deformities and disorders

0.00

-0.00

0.0

1.7

—

Other and unspecified coagulation defects

0.00

-0.00

0.0

1.7

—

Pure hyperglyceridaemia

0.00

-0.00

0.0

1.7

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

1.7

—

Acute posthaemorrhagic anaemia

0.00

-0.00

0.0

1.5

—

Unspecified dementia

0.00

-0.00

0.0

2.0

—

Benign neoplasm: Larynx

0.00

-0.00

0.0

1.7

—

Follicular lymphoma, hilmo

0.00

-0.00

0.0

1.2

—

Other facial nerve disorders

0.00

-0.00

0.0

1.8

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

2.0

—

Otosclerosis

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.7

—

Benign neoplasm of ovary

0.00

-0.00

0.0

3.1

—

Disturbance of activity and attention

0.00

-0.00

0.0

1.5

—

Malignant melanoma of skin

0.00

-0.00

0.0

2.2

—

Emotionally unstable personality disorder

0.00

-0.00

0.0

1.9

—

Malignant neoplasm of pancreas

0.00

-0.00

0.0

1.8

—

Melanocytic naevi, other sites/unspecified

0.00

-0.00

0.0

1.6

—

Cardiac arrest

0.00

-0.00

0.0

3.2

—

Paralytic ileus

0.00

-0.00

0.0

1.2

—

Pediculosis, acariasis and other infestations

0.00

-0.00

0.0

1.7

—

Presbycusis

0.00

-0.00

0.0

1.7

—

Other symptoms and signs involving the circulatory and respiratory systems

0.00

-0.00

0.0

1.4

—

Enterocolitis due to Clostridium difficile

0.00

-0.00

0.0

1.8

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.9

—

Other keratitis

0.00

-0.00

0.0

2.6

—

Certain zoonotic bacterial diseases

0.00

-0.00

0.0

1.7

—

Use of rivastigmine

0.00

-0.00

0.0

1.4

—

Pneumonitis due to solids and liquids

0.00

-0.00

0.0

1.9

—

Subarachnoid haemorrhage

0.00

-0.00

0.0

1.8

—

Hereditary corneal dystrophies

0.00

-0.00

0.0

1.2

—

Herpesviral [herpes simplex] infections

0.00

-0.00

0.0

1.7

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.9

—

Other diseases of biliary tract

0.00

-0.00

0.0

1.7

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.8

—

Retained placenta and membranes, without haemorrhage

0.00

-0.00

0.0

1.8

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

-0.00

0.0

1.8

—

Pneumothorax

0.00

-0.00

0.0

1.8

—

Viral conjunctivitis

0.00

-0.00

0.0

1.6

—

Cardiomyopathy, other and unspecified

0.00

-0.00

0.0

1.6

—

Osteomyelitis

0.00

-0.00

0.0

1.9

—

Diabetic maculopathy, excluding more controls

0.00

-0.00

0.0

1.8

—

Parkinson's disease, strict definition, excluding more controls

0.00

-0.00

0.0

4.0

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

4.0

—

Speech and linguistic disorders, excluding more controls

0.00

-0.00

0.0

1.0

—

Other surgical follow-up care

0.00

-0.00

0.0

1.8

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Isoniazid [Presence] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS